Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against Rs 54.49 crore during the previous quarter ended June 2023. Sales rose 10.76% to Rs 215.80 crore in the quarter ended June 2024 as against Rs 194.83 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 215.80 | 194.83 | 11 |
| OPM % | 37.66 | 37.03 | - |
| PBDT | 92.70 | 84.08 | 10 |
| PBT | 79.52 | 71.04 | 12 |
| NP | 59.59 | 54.49 | 9 |